Luqing Tong

784 total citations
24 papers, 516 citations indexed

About

Luqing Tong is a scholar working on Genetics, Oncology and Immunology. According to data from OpenAlex, Luqing Tong has authored 24 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 10 papers in Oncology and 8 papers in Immunology. Recurrent topics in Luqing Tong's work include Glioma Diagnosis and Treatment (17 papers), MicroRNA in disease regulation (6 papers) and Ferroptosis and cancer prognosis (5 papers). Luqing Tong is often cited by papers focused on Glioma Diagnosis and Treatment (17 papers), MicroRNA in disease regulation (6 papers) and Ferroptosis and cancer prognosis (5 papers). Luqing Tong collaborates with scholars based in China, United States and Germany. Luqing Tong's co-authors include Xuejun Yang, Yi Li, Peidong Liu, Shengping Yu, Haiwen Ma, Yang Xie, Jiabo Li, Hai Long, Zhennan Tao and Feng Yuan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Neurosurgery.

In The Last Decade

Luqing Tong

22 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luqing Tong China 12 237 177 169 141 125 24 516
Gaochao Guo China 10 198 0.8× 138 0.8× 162 1.0× 138 1.0× 155 1.2× 17 453
Xiangdong Zhao China 14 324 1.4× 120 0.7× 210 1.2× 196 1.4× 72 0.6× 24 580
Hecheng Zhu China 14 295 1.2× 132 0.7× 110 0.7× 157 1.1× 54 0.4× 29 530
James Ross United States 12 184 0.8× 214 1.2× 140 0.8× 91 0.6× 174 1.4× 24 559
Haibin Wu China 13 249 1.1× 134 0.8× 145 0.9× 101 0.7× 57 0.5× 32 513
Isabele Cristiana Iser Brazil 12 272 1.1× 108 0.6× 140 0.8× 147 1.0× 221 1.8× 18 641
Chunyu Gu China 14 413 1.7× 76 0.4× 164 1.0× 139 1.0× 186 1.5× 31 639
María González-Tablas Spain 8 249 1.1× 143 0.8× 120 0.7× 135 1.0× 256 2.0× 12 616
Qin Niu China 13 381 1.6× 103 0.6× 145 0.9× 265 1.9× 71 0.6× 17 565
Chen Zhu China 16 343 1.4× 164 0.9× 180 1.1× 208 1.5× 100 0.8× 35 680

Countries citing papers authored by Luqing Tong

Since Specialization
Citations

This map shows the geographic impact of Luqing Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luqing Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luqing Tong more than expected).

Fields of papers citing papers by Luqing Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luqing Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luqing Tong. The network helps show where Luqing Tong may publish in the future.

Co-authorship network of co-authors of Luqing Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Luqing Tong. A scholar is included among the top collaborators of Luqing Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luqing Tong. Luqing Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Tong, Luqing, Ke Ye, Qun Chen, et al.. (2024). Proteomics shows that brain metastases of lung adenocarcinoma overexpress ribosomal proteins in response to gamma knife radiosurgery. Scientific Reports. 14(1). 15646–15646. 2 indexed citations
4.
Li, Jiabo, Xuya Wang, Luqing Tong, et al.. (2023). TMIC-14. CLEC5A REGULATES TAM POLARIZATION, TME IMMUNOSUPPRESSION AND DISEASE PROGRESSION IN GLIOBLASTOMA. Neuro-Oncology. 25(Supplement_5). v281–v281. 1 indexed citations
5.
Li, Jiabo, Xuya Wang, Tatiana Carneiro-Lobo, et al.. (2022). TMIC-21. THE ROLE OF CLEC5A ON M2-LIKE TUMOR-ASSOCIATED MACROPHAGES POLARIZATION AND DISEASE PROGRESSION IN GLIOBLASTOMA. Neuro-Oncology. 24(Supplement_7). vii275–vii276. 1 indexed citations
6.
Choi, John, Ravi Medikonda, Timothy Kim, et al.. (2021). Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma. OncoImmunology. 10(1). 1956142–1956142. 37 indexed citations
7.
Zhang, Jinhao, Jiabo Li, Feng Yuan, et al.. (2021). MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma. Disease Markers. 2021. 1–13. 15 indexed citations
8.
Tong, Luqing, Jiabo Li, Xuya Wang, et al.. (2020). ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma. Theranostics. 10(13). 5943–5956. 112 indexed citations
9.
Tong, Luqing, et al.. (2020). Immunological and clinicopathological characteristics of C1RL in 2120 glioma patients. BMC Cancer. 20(1). 931–931. 9 indexed citations
10.
Yang, Xuejun, et al.. (2020). A contemporary molecular view of diffuse gliomas with implications for diagnosis. SHILAP Revista de lepidopterología. 3(2). 38–38. 1 indexed citations
11.
Li, Yi, Gaochao Guo, Jiabo Li, et al.. (2020). IKBKE, a prognostic factor preferentially expressed in mesenchymal glioblastoma, modulates tumoral immunosuppression through the STAT3/PD‐L1 pathway. SHILAP Revista de lepidopterología. 10(3). 3 indexed citations
12.
Li, Jiabo, Luqing Tong, Yi Li, et al.. (2019). ACT001 inhibits the neurosphere formation and stemness maintenance of U87-MG glioma stem cells through STAT3 signaling pathway. Zhonghua shenjing waike zazhi. 35(11). 1160–1166. 1 indexed citations
13.
Li, Yi, Xingchen Zhou, Tao Li, et al.. (2019). Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4. Journal of Experimental & Clinical Cancer Research. 38(1). 339–339. 105 indexed citations
14.
Tong, Luqing, Jiabo Li, John Choi, et al.. (2019). CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma. Cancer Gene Therapy. 27(9). 669–679. 20 indexed citations
15.
Yuan, Feng, Yi Li, Hai Long, et al.. (2019). Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses. Disease Markers. 2019. 1–13. 13 indexed citations
16.
Yuan, Feng, Haolang Ming, Yingshuai Wang, et al.. (2019). Molecular and clinical characterization of Galectin‐9 in glioma through 1,027 samples. Journal of Cellular Physiology. 235(5). 4326–4334. 39 indexed citations
17.
Long, Hai, Peidong Liu, Shengping Yu, et al.. (2018). Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-κB(p65) Signaling. Cellular Physiology and Biochemistry. 51(6). 2925–2937. 18 indexed citations
18.
Tong, Luqing, Yi Li, Peidong Liu, et al.. (2018). Tumour cell dormancy as a contributor to the reduced survival of GBM patients who received standard therapy. Oncology Reports. 40(1). 463–471. 15 indexed citations
19.
Tao, Zhennan, Tao Li, Haiwen Ma, et al.. (2018). Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation. Cell Death and Disease. 9(11). 1063–1063. 49 indexed citations
20.
Tong, Luqing, Yi Li, Chen Zhang, et al.. (2017). Three-dimensional hydrogel is suitable for targeted investigation of amoeboid migration of glioma cells. Molecular Medicine Reports. 17(1). 250–256. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gaochao Guo Breakdown of academic impact, for papers by Xiangdong Zhao Breakdown of academic impact, for papers by Hecheng Zhu Breakdown of academic impact, for papers by James Ross Breakdown of academic impact, for papers by Haibin Wu Breakdown of academic impact, for papers by Isabele Cristiana Iser Breakdown of academic impact, for papers by Chunyu Gu Breakdown of academic impact, for papers by María González-Tablas Breakdown of academic impact, for papers by Qin Niu Breakdown of academic impact, for papers by Chen Zhu
Rankless by CCL
2026